MENU

3 All Ords shares at 52-week lows: Is it time to invest?

Although the All Ordinaries (Index: ^AXAO) (ASX: XAO) is trading close to a five-month high, not all shares on the index have been able to follow the market higher this year.

Three shares that sank to 52-week lows or worse this week are listed below. Is this a buying opportunity?

The Amaysim Australia Ltd (ASX: AYS) share price continued its decline and sank to an all-time low of 63 cents on Tuesday. The telco company’s shares have come under significant selling pressure since it announced a $50.6 million underwritten capital raising at 60 cents per share. This was a massive 36% discount to the last close price prior to the announcement. The net proceeds from the entitlement offer are to be used to reduce the company’s debt and provide additional balance sheet strength and flexibility to support its investment in new strategic growth initiatives. Whilst its shares look reasonably cheap now, I’m not a big fan of the company and would suggest investors focus on opportunities elsewhere.

The Auscann Group Holdings Ltd (ASX: AC8) share price tumbled to a 52-week low of 38 cents yesterday. Last week the medicinal cannabis company released its half year results and revealed revenue of just $0.47 million a loss of $4.4 million. I suspect that investors are disappointed with the lack of progress being made in the industry and have been selling shares and moving onto other opportunities.

The Bega Cheese Ltd (ASX: BGA) share price dropped to a two-year low of $4.52 on Tuesday. The food company’s shares have come under pressure since the release of a disappointing half year result last month. In the first half of FY 2019 Bega Cheese posted a 6% increase in revenue to $649.2 million and a 48.3% decline in normalised half year profit to $18.9 million. However, management appears confident that its second half performance will be stronger and advised that it expects to achieve full year normalised EBITDA growth of 12%. If it delivers on this then it could prove to be a good investment at the current level.

Analyst Names 3 Top Growth Shares to Buy in March

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!